Immunophenotypic and cytogenetic evolution patterns of the neoplastic plasma cells in multiple myeloma relapsed after stem cell transplant

Reha M. Toydemir, Anton V. Rets, Jerry W. Hussong, Djordje Atanackovic, Mohamed Salama

Research output: Contribution to journalArticle

Abstract

Multiple myeloma (MM) is a neoplasm characterized by proliferation of clonal plasma cells (PCs) and a combination of clinical manifestations. Flow cytometry is an important method for diagnosing and monitoring of MM. Cytogenetic profiling of neoplastic PCs provides important prognostic information. Although stem cell transplantation (SCT) has significantly improved the overall survival of patients with MM, most SCT recipients relapse. We have studied the immunophenotypic and cytogenetic dissimilarities in the neoplastic PCs before SCT and after relapse in patients with initial complete remission, and investigated a possible influence of such dissimilarities on the patients’ survival. We retrospectively reviewed results of flow cytometric studies of bone marrow specimens from 46 patients with MM who underwent SCT, demonstrated a complete initial response, but subsequently relapsed. In nine of these patients, fluorescence in situ hybridization (FISH) studies were performed both pre-SCT and post-relapse. We have shown a significant flow cytometric and cytogenetic diversity of the neoplastic PCs in relapsed MM post-SCT. Such changes were detected in a considerable number of cases (47.8% and 44.4%, respectively). The most frequent cytogenetic changes indicate an emergence of possibly a more aggressive PC clone, known to be associated with worse prognosis and poorer outcome. Our study has demonstrated that the acquisition of immunophenotypic changes predicts worse overall survival.

Original languageEnglish (US)
Pages (from-to)75-80
Number of pages6
JournalJournal of Hematopathology
Volume11
Issue number3
DOIs
StatePublished - Sep 1 2018
Externally publishedYes

Fingerprint

Stem Cell Transplantation
Plasma Cells
Multiple Myeloma
Cytogenetics
Stem Cells
Transplants
Recurrence
Survival
Fluorescence In Situ Hybridization
Flow Cytometry
Clone Cells
Bone Marrow
Neoplasms

Keywords

  • Flow cytometry
  • Karyotype
  • Multiple myeloma
  • Relapse
  • Stem cell transplant

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Hematology

Cite this

Immunophenotypic and cytogenetic evolution patterns of the neoplastic plasma cells in multiple myeloma relapsed after stem cell transplant. / Toydemir, Reha M.; Rets, Anton V.; Hussong, Jerry W.; Atanackovic, Djordje; Salama, Mohamed.

In: Journal of Hematopathology, Vol. 11, No. 3, 01.09.2018, p. 75-80.

Research output: Contribution to journalArticle

Toydemir, Reha M. ; Rets, Anton V. ; Hussong, Jerry W. ; Atanackovic, Djordje ; Salama, Mohamed. / Immunophenotypic and cytogenetic evolution patterns of the neoplastic plasma cells in multiple myeloma relapsed after stem cell transplant. In: Journal of Hematopathology. 2018 ; Vol. 11, No. 3. pp. 75-80.
@article{464e5c4b38714797aaeb130f24fb015d,
title = "Immunophenotypic and cytogenetic evolution patterns of the neoplastic plasma cells in multiple myeloma relapsed after stem cell transplant",
abstract = "Multiple myeloma (MM) is a neoplasm characterized by proliferation of clonal plasma cells (PCs) and a combination of clinical manifestations. Flow cytometry is an important method for diagnosing and monitoring of MM. Cytogenetic profiling of neoplastic PCs provides important prognostic information. Although stem cell transplantation (SCT) has significantly improved the overall survival of patients with MM, most SCT recipients relapse. We have studied the immunophenotypic and cytogenetic dissimilarities in the neoplastic PCs before SCT and after relapse in patients with initial complete remission, and investigated a possible influence of such dissimilarities on the patients’ survival. We retrospectively reviewed results of flow cytometric studies of bone marrow specimens from 46 patients with MM who underwent SCT, demonstrated a complete initial response, but subsequently relapsed. In nine of these patients, fluorescence in situ hybridization (FISH) studies were performed both pre-SCT and post-relapse. We have shown a significant flow cytometric and cytogenetic diversity of the neoplastic PCs in relapsed MM post-SCT. Such changes were detected in a considerable number of cases (47.8{\%} and 44.4{\%}, respectively). The most frequent cytogenetic changes indicate an emergence of possibly a more aggressive PC clone, known to be associated with worse prognosis and poorer outcome. Our study has demonstrated that the acquisition of immunophenotypic changes predicts worse overall survival.",
keywords = "Flow cytometry, Karyotype, Multiple myeloma, Relapse, Stem cell transplant",
author = "Toydemir, {Reha M.} and Rets, {Anton V.} and Hussong, {Jerry W.} and Djordje Atanackovic and Mohamed Salama",
year = "2018",
month = "9",
day = "1",
doi = "10.1007/s12308-018-0330-6",
language = "English (US)",
volume = "11",
pages = "75--80",
journal = "Journal of Hematopathology",
issn = "1865-5785",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Immunophenotypic and cytogenetic evolution patterns of the neoplastic plasma cells in multiple myeloma relapsed after stem cell transplant

AU - Toydemir, Reha M.

AU - Rets, Anton V.

AU - Hussong, Jerry W.

AU - Atanackovic, Djordje

AU - Salama, Mohamed

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Multiple myeloma (MM) is a neoplasm characterized by proliferation of clonal plasma cells (PCs) and a combination of clinical manifestations. Flow cytometry is an important method for diagnosing and monitoring of MM. Cytogenetic profiling of neoplastic PCs provides important prognostic information. Although stem cell transplantation (SCT) has significantly improved the overall survival of patients with MM, most SCT recipients relapse. We have studied the immunophenotypic and cytogenetic dissimilarities in the neoplastic PCs before SCT and after relapse in patients with initial complete remission, and investigated a possible influence of such dissimilarities on the patients’ survival. We retrospectively reviewed results of flow cytometric studies of bone marrow specimens from 46 patients with MM who underwent SCT, demonstrated a complete initial response, but subsequently relapsed. In nine of these patients, fluorescence in situ hybridization (FISH) studies were performed both pre-SCT and post-relapse. We have shown a significant flow cytometric and cytogenetic diversity of the neoplastic PCs in relapsed MM post-SCT. Such changes were detected in a considerable number of cases (47.8% and 44.4%, respectively). The most frequent cytogenetic changes indicate an emergence of possibly a more aggressive PC clone, known to be associated with worse prognosis and poorer outcome. Our study has demonstrated that the acquisition of immunophenotypic changes predicts worse overall survival.

AB - Multiple myeloma (MM) is a neoplasm characterized by proliferation of clonal plasma cells (PCs) and a combination of clinical manifestations. Flow cytometry is an important method for diagnosing and monitoring of MM. Cytogenetic profiling of neoplastic PCs provides important prognostic information. Although stem cell transplantation (SCT) has significantly improved the overall survival of patients with MM, most SCT recipients relapse. We have studied the immunophenotypic and cytogenetic dissimilarities in the neoplastic PCs before SCT and after relapse in patients with initial complete remission, and investigated a possible influence of such dissimilarities on the patients’ survival. We retrospectively reviewed results of flow cytometric studies of bone marrow specimens from 46 patients with MM who underwent SCT, demonstrated a complete initial response, but subsequently relapsed. In nine of these patients, fluorescence in situ hybridization (FISH) studies were performed both pre-SCT and post-relapse. We have shown a significant flow cytometric and cytogenetic diversity of the neoplastic PCs in relapsed MM post-SCT. Such changes were detected in a considerable number of cases (47.8% and 44.4%, respectively). The most frequent cytogenetic changes indicate an emergence of possibly a more aggressive PC clone, known to be associated with worse prognosis and poorer outcome. Our study has demonstrated that the acquisition of immunophenotypic changes predicts worse overall survival.

KW - Flow cytometry

KW - Karyotype

KW - Multiple myeloma

KW - Relapse

KW - Stem cell transplant

UR - http://www.scopus.com/inward/record.url?scp=85052670079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052670079&partnerID=8YFLogxK

U2 - 10.1007/s12308-018-0330-6

DO - 10.1007/s12308-018-0330-6

M3 - Article

AN - SCOPUS:85052670079

VL - 11

SP - 75

EP - 80

JO - Journal of Hematopathology

JF - Journal of Hematopathology

SN - 1865-5785

IS - 3

ER -